advanced search

Skin Drug Delivery: Transdermal & Microneedles84

Issue No #84  March 19th, 2018


Download PDF


Inside the magazine

DISSOLVABLE MICRONEEDLES: APPLICATIONS AND OPPORTUNITIES
SKIN
Dr Jung Dong Kim
Raphas
DISSOLVABLE MICRONEEDLES: APPLICATIONS AND OPPORTUNITIES
Jung Dong Kim and Do Hyeon Jeong discuss dissolvable microneedle technology and its myriad uses.
SILICA NANO-SOLUTIONS FOR SKIN DELIVERY
SKIN
Dr Aparajita Khatri
Ceramisphere Health
SILICA NANO-SOLUTIONS FOR SKIN DELIVERY
Aparajita Khatri and Christophe A Barbé outline the growth of the dermal delivery market, as well as the challenges it faces. The authors go on to detail a nanocomposite lidocaine patch.
AN INTRADERMAL PLATFORM BUILT FOR INDUSTRY AND PATIENTS
EARLY INSIGHT
Dr Moe Wehbe
Microdermics
AN INTRADERMAL PLATFORM BUILT FOR INDUSTRY AND PATIENTS
Moe Wehbe, Iman Mansoor and Sahan Ranamukha discuss the potential of intradermal injection for modern medicines and its advantages over the subcutaneous route.
SIMPLIFIED DRUG AND VACCINE DELIVERY USING MICRON’S MICRONEEDLE PATCH
EARLY INSIGHT
Dr Mark Prausnitz
Micron Biomedical
SIMPLIFIED DRUG AND VACCINE DELIVERY USING MICRON’S MICRONEEDLE PATCH
Devin V McAllister, Sebastien Henry and Mark Prausnitz introduce the company’s dissolving microneedle patch technology, which has global potential, including in the developing world, across a range of vaccine and therapeutic applications.
COST-EFFECTIVE APPROACHES FOR SUCCESSFUL GENERIC DERMAL DRUG PRODUCT AUTHORISATIONS
SKIN
Prof Marc Brown
MedPharm
COST-EFFECTIVE APPROACHES FOR SUCCESSFUL GENERIC DERMAL DRUG PRODUCT AUTHORISATIONS
Marc Brown, Jon Lenn and Jeremy Dummond discuss various methods and advantages of in vitro bioequivalence studies for topical skin application, and how MedPharm’s unique technologies and experience can be invaluable in the effective development of generics in this field.
QUALITY BY DESIGN IN TDS DEVELOPMENT: BENEFIT OR BUREAUCRATIC BURDEN?
EXPERT VIEW
Petra Botzem
QUALITY BY DESIGN IN TDS DEVELOPMENT: BENEFIT OR BUREAUCRATIC BURDEN?
Petra Botzem and Thomas Hille discuss the Quality-by-Design approach to the development of transdermal drug delivery systems as laid out in ICH guideline Q8.
TERIPARATIDE MICRO-PATCH™: A SOLID MICRONEEDLE PRODUCT NEARING CLINICAL TRIALS
SKIN
Dr Faz Chowhury
Nemaura Pharma
TERIPARATIDE MICRO-PATCH™: A SOLID MICRONEEDLE PRODUCT NEARING CLINICAL TRIALS
Faz Chowdhury details a Micro-Patch™ solid formulation of the parathyroid hormone analogue, teriparatide, for the treatment of osteoporosis.
Top

W3 Total Cache is currently running in Pro version Development mode.